Background	B-O
Given	B-O
the	B-O
increasing	B-O
burden	B-O
of	I-LF
chronic	B-LF
conditions,	B-O
multimorbidity	B-O
is	B-O
now	B-O
a	B-O
priority	B-O
for	B-O
healthcare	B-O
and	B-O
public	B-O
health	B-O
systems	B-O
worldwide.	B-O
Appropriate	B-O
methodological	B-O
approaches	B-O
for	B-O
assessing	B-O
the	B-O
phenomenon	B-O
have	B-O
not	B-O
yet	B-O
been	B-O
established,	B-O
resulting	B-O
in	B-O
inconsistent	B-O
and	B-O
incomplete	B-O
descriptions.	B-O
We	B-O
aimed	B-O
to	I-LF
estimate	B-O
and	B-O
characterize	B-O
the	B-O
burden	B-O
of	I-LF
multimorbidity	B-O
in	B-O
the	B-O
adult	B-O
population	B-O
in	B-O
France	B-O
in	B-O
terms	B-O
of	I-LF
number	B-O
and	B-O
type	B-O
of	I-LF
conditions,	B-O
type	B-O
of	I-LF
underlying	B-O
mechanisms,	B-O
and	B-O
analysis	B-O
of	I-LF
the	B-O
joint	B-O
effects	B-O
for	B-O
identifying	B-O
combinations	B-O
with	B-O
the	B-O
most	B-O
deleterious	B-O
interaction	I-LF
effects	B-O
on	B-O
health	B-O
status.	B-O
Methods	B-O
and	B-O
findings	B-O
We	B-O
used	B-O
a	B-O
multistep	B-O
approach	B-O
to	I-LF
analyze	B-O
cross-sectional	B-O
and	B-O
longitudinal	B-O
data	B-O
from	B-O
2	B-O
large	B-O
nationwide	B-O
representative	B-O
surveys:	B-O
2010/2014	B-O
waves	B-O
of	I-LF
the	B-O
Health,	B-O
Health	I-LF
Care,	B-O
and	B-O
Insurance	B-O
Survey	B-O
identify	B-O
the	B-O
relevant	B-O
conditions	B-O
for	B-O
inclusion	B-O
in	B-O
the	B-O
multimorbidity	B-O
analysis;	B-O
.	B-O
This	B-O
categorization	B-O
was	B-O
practically	B-O
implemented	B-O
in	B-O
a	B-O
standardized	B-O
way,	B-O
through	B-O
the	B-O
following	B-O
steps:	B-O
The	B-O
age-	B-O
and	B-O
sex-adjusted	B-O
odds	B-LF
ratio	I-LF
to	I-LF
supermultiplicative	B-O
.	B-O
Download:	B-O
PPT	B-O
PowerPoint	B-O
slide	B-O
PNG	B-O
larger	B-O
image	B-O
TIFF	B-O
original	B-O
image	B-O
Fig	B-O
3.	B-O
Interaction	B-O
continuum	B-O
and	B-O
5	B-O
categories	B-O
of	I-LF
interaction	I-LF
on	B-O
additive	B-O
and	B-O
multiplicative	B-O
scales	B-O
considered	B-O
in	B-O
this	B-O
study.	B-O
RoOR,	B-O
ratio	I-LF
of	I-LF
odds	B-LF
ratios;	B-O
RERI,	B-O
relative	B-LF
excess	I-LF
risk	I-LF
due	I-LF
to	I-LF
interaction.	B-O
Joint	B-O
effects	B-O
and	B-O
interactions	B-O
of	I-LF
associated	B-O
conditions	B-O
on	B-O
functioning	B-O
between	B-O
the	B-O
48	B-O
selected	B-O
chronic	B-LF
conditions	B-O
by	B-O
visualizing	B-O
3	B-O
main	B-O
aggregates	B-O
of	I-LF
associations	B-O
that	B-O
are	B-O
consistent	B-O
across	B-O
time	B-O
frames:	B-O
and	B-O
analyzed	B-O
as	B-O
a	B-O
3-category	B-O
variable.	B-O
A	B-O
light	B-O
blue	B-O
box	B-O
indicates	B-O
an	B-O
OR	B-AC
≤2.	B-O
A	B-O
star	B-O
sign	B-O
.	B-O
Dyads	B-O
with	B-O
multiplicative	B-O
or	B-O
supermultiplicative	B-O
interactions	B-O
included	B-O
obesity,	B-O
chronic	B-LF
obstructive	I-LF
pulmonary	I-LF
disease,	B-O
migraine	B-O
accompanying	B-O
other	B-O
conditions,	B-O
inflammatory	B-O
arthritis	B-O
and	B-O
several	B-O
forms	B-O
of	I-LF
osteoarthritis,	B-O
cardiac	B-O
rhythm	B-O
disorders,	B-O
and	B-O
stroke;	B-O
dyads	B-O
with	B-O
additive	B-O
interactions	B-O
included	B-O
cardiometabolic	B-O
conditions,	B-O
musculoskeletal	B-O
conditions,	B-O
and	B-O
injury	B-O
sequelae	B-O
with	B-O
other	B-O
conditions.	B-O
Depression	B-O
and	B-O
anxiety	B-O
had	B-O
a	B-O
subadditive	B-O
interaction:	B-O
When	B-O
associated	B-O
with	B-O
another	B-O
condition,	B-O
they	B-O
had	B-O
an	B-O
additive	B-O
interaction.	B-O
The	B-O
patterns	B-O
of	I-LF
effects	B-O
were	B-O
similar	B-O
across	B-O
time	B-O
frames,	B-O
although	B-O
the	B-O
interactions	B-O
shifted	B-O
to	I-LF
the	B-O
additive	B-O
side	B-O
for	B-O
the	B-O
lifetime	B-O
frame	B-O
compared	B-O
to	I-LF
1-year	B-O
time	B-O
frame	B-O
and	B-O
perceived	B-O
health	B-O
(bad	B-O
or	B-O
very	B-O
bad	B-O
SRH,	B-O
lower	B-O
left	B-O
panel	B-O
below	B-O
the	B-O
diagonal)	B-O
in	B-O
ESPS	B-AC
(Panel	B-O
A)	B-O
and	B-O
HSM	B-AC
surveys	B-O
(Panel	B-O
B).	B-O
Interactions	B-O
are	B-O
evaluated	B-O
by	B-O
the	B-O
RERI	B-AC
(see	B-O
S8	B-O
Table	B-O
for	B-O
values)	B-O
and	B-O
represented	B-O
using	B-O
a	B-O
color	B-O
scale	B-O
from	B-O
green	B-O
(low	B-O
values:	B-O
subadditive	B-O
or	B-O
additive)	B-O
to	I-LF
red	B-O
(high	B-O
values:	B-O
multiplicative	B-O
or	B-O
supermultiplicative).	B-O
Only	B-O
dyads	B-O
with	B-O
a	B-O
frequency	B-O
of	I-LF
≥0.25%	B-O
in	B-O
at	B-O
least	B-O
1	B-O
survey	B-O
sample	B-O
are	B-O
considered.	B-O
BMI,	B-O
body	B-LF
mass	I-LF
index;	B-O
ESPS,	B-O
Enquête	B-LF
Santé	I-LF
et	I-LF
Protection	I-LF
Sociale;	B-O
GALI:	B-O
Global	B-LF
Activity	I-LF
Limitation	I-LF
Indicator;	B-O
HSM,	B-O
Enquête	B-LF
Handicap–Santé	I-LF
Ménages;	B-O
RERI,	B-O
relative	B-LF
excess	I-LF
risk	I-LF
due	I-LF
to	I-LF
interaction;	B-O
SRH:	B-O
Self-Reported	B-LF
Health	I-LF
indicator.	B-O
Discussion	B-O
The	B-O
use	B-O
of	I-LF
a	B-O
comprehensive	B-O
and	B-O
multistep	B-O
analytical	B-O
approach	B-O
to	I-LF
analyze	B-O
2	B-O
large	B-O
representative	B-O
general	B-O
population	B-O
samples	B-O
with	B-O
cross-sectional	B-O
and	B-O
longitudinal	B-O
data	B-O
on	B-O
numerous	B-O
chronic	B-LF
conditions	B-O
and	B-O
a	B-O
broad	B-O
range	B-O
of	I-LF
health	B-O
indicators	B-O
allowed	B-O
us	B-O
to	I-LF
estimate	B-O
and	B-O
characterize	B-O
the	B-O
burden	B-O
of	I-LF
multimorbidity	B-O
in	B-O
France.	B-O
This	B-O
study	B-O
also	B-O
makes	B-O
novel	B-O
contributions	B-O
to	I-LF
3	B-O
crucial	B-O
aspects	B-O
of	I-LF
multimorbidity	B-O
assessments	B-O
and	B-O
measurements:	B-O
(1)	B-O
proposing	B-O
a	B-O
comprehensive	B-O
method	B-O
for	B-O
estimating	B-O
and	B-O
characterizing	B-O
the	B-O
burden	B-O
based	B-O
on	B-O
the	B-O
health	B-O
impacts;	B-O
(2)	B-O
determining	B-O
the	B-O
underlying	B-O
mechanisms	B-O
to	I-LF
explain	B-O
the	B-O
observed	B-O
associations;	B-O
and	B-O
(3)	B-O
identifying	B-O
multimorbid	B-O
combinations	B-O
with	B-O
a	B-O
high	B-O
impact	B-O
and	B-O
the	B-O
most	B-O
deleterious	B-O
interaction	I-LF
effects	B-O
on	B-O
health.	B-O
Burden	I-LF
of	I-LF
multimorbidity	B-O
in	B-O
France	B-O
Our	B-O
study	B-O
is	B-O
the	B-O
first	B-O
to	I-LF
characterize	B-O
the	B-O
burden	B-O
of	I-LF
multimorbidity	B-O
in	B-O
France.	B-O
Estimates	B-O
of	I-LF
the	B-O
prevalence	B-O
of	I-LF
specific	B-O
conditions	B-O
included	B-O
in	B-O
this	B-O
study	B-O
are	B-O
similar	B-O
to	I-LF
those	B-O
previously	B-O
reported	B-O
in	B-O
this	B-O
country	B-O
,	B-O
while	B-O
estimates	B-O
of	I-LF
the	B-O
prevalence	B-O
of	I-LF
multimorbidity	B-O
and	B-O
specific	B-O
multimorbid	B-O
combinations	B-O
as	B-O
well	B-O
as	B-O
the	B-O
observed	B-O
higher	B-O
prevalence	B-O
among	B-O
women	B-O
are	B-O
in	B-O
line	B-O
with	B-O
other	B-O
studies	B-O
conducted	B-O
in	B-O
Europe	B-O
[	B-O
5	B-O
,	B-O
8	B-O
]	B-O
and	B-O
worldwide	B-O
.	B-O
Our	B-O
study	B-O
strongly	B-O
confirms	B-O
that	B-O
multimorbidity	B-O
is	B-O
not	B-O
just	B-O
a	B-O
problem	B-O
of	I-LF
old	B-O
age	B-O
[	B-O
30	B-O
–	B-O
33	B-O
]:	B-O
In	B-O
middle	B-O
age	B-O
(35	B-O
to	I-LF
54	B-O
years),	B-O
it	B-O
affects	B-O
1	B-O
in	B-O
6	B-O
men	B-O
and	B-O
1	B-O
in	B-O
4	B-O
women.	B-O
This	B-O
study	B-O
also	B-O
found	B-O
marked	B-O
socioeconomic	B-O
gradients,	B-O
with	B-O
participants,	B-O
especially	B-O
women,	B-O
with	B-O
lower	B-O
education	B-O
and	B-O
socioeconomic	B-O
status	B-O
exhibiting	B-O
higher	B-O
multimorbidity	B-O
rates	B-O
earlier	B-O
in	B-O
the	B-O
life,	B-O
as	B-O
already	B-O
observed	B-O
[	B-O
5	B-O
,	B-O
34	B-O
].	B-O
Estimating	B-O
and	B-O
characterizing	B-O
the	B-O
burden	B-O
of	I-LF
multimorbidity	B-O
This	B-O
study	B-O
showed	B-O
that	B-O
a	B-O
large	B-O
number	B-O
of	I-LF
chronic	B-LF
conditions	B-O
(almost	B-O
50)	B-O
significantly	B-O
and	B-O
independently	B-O
impact	B-O
mortality,	B-O
activity	B-O
limitations,	B-O
or	B-O
perceived	B-O
heath	B-O
in	B-O
adults.	B-O
With	B-O
the	B-O
exception	B-O
of	I-LF
the	B-O
Global	B-LF
Burden	I-LF
of	I-LF
Diseases	I-LF
(GBD)	B-O
program,	B-O
which	B-O
included	B-O
over	B-O
200	B-O
noncommunicable	B-O
diseases	B-O
in	B-O
its	B-O
2017	B-O
updated	B-O
version	B-O
,	B-O
most	B-O
public	B-O
health	B-O
agencies	B-O
worldwide	B-O
monitor	B-O
much	B-O
fewer	B-O
chronic	B-LF
conditions.	B-O
For	B-O
example,	B-O
the	B-O
US	B-O
Centers	B-O
for	B-O
Disease	B-O
Control	B-O
monitors	B-O
10	B-O
conditions	B-O
in	B-O
the	B-O
Behavioral	B-O
Risk	B-O
Factor	B-O
Surveillance	B-O
System	B-O
,	B-O
while	B-O
Public	B-O
Health	I-LF
England	B-O
generates	B-O
prevalence	B-O
estimates	B-O
for	B-O
12	B-O
health	B-O
problems	B-O
according	B-O
to	I-LF
“health	B-O
profiles,”	B-O
to	I-LF
which	B-O
modeled	B-O
estimates	B-O
of	I-LF
7	B-O
conditions	B-O
are	B-O
added	B-O
.	B-O
Until	B-O
a	B-O
consensus	B-O
is	B-O
reached	B-O
about	B-O
which	B-O
chronic	B-LF
conditions	B-O
and	B-O
combinations	B-O
of	I-LF
conditions	B-O
should	B-O
be	B-O
monitored	B-O
regionally	B-O
or	B-O
internationally,	B-O
this	B-O
study	B-O
pleads	B-O
for	B-O
the	B-O
assessment	B-O
of	I-LF
a	B-O
large	B-O
but	B-O
also	B-O
reasoned	B-O
list	B-O
of	I-LF
conditions	B-O
that	B-O
independently	B-O
impact	B-O
mortality,	B-O
disability,	B-O
or	B-O
perceived	B-O
health.	B-O
This	B-O
requirement	B-O
for	B-O
an	B-O
independent	B-O
impact	B-O
on	B-O
health	B-O
enables	B-O
us	B-O
to	I-LF
move	B-O
beyond	B-O
the	B-O
debate	B-O
about	B-O
which	B-O
type	B-O
of	I-LF
condition	B-O
(risk	B-O
factors,	B-O
symptoms,	B-O
syndromes,	B-O
diseases)	B-O
should	B-O
be	B-O
considered	B-O
in	B-O
the	B-O
multimorbidity	B-O
assessment	B-O
:	B-O
Any	B-O
chronic	B-LF
or	B-O
recurrent	B-O
condition	B-O
found	B-O
in	B-O
the	B-O
current	B-O
nosology	B-O
(as	B-O
reflected	B-O
in	B-O
the	B-O
International	B-LF
Classification	I-LF
of	I-LF
Diseases,	B-O
which	B-O
includes	B-O
diseases	B-O
and	B-O
sometimes	B-O
syndromes	B-O
and	B-O
symptoms)	B-O
with	B-O
an	B-O
independent	B-O
impact	B-O
on	B-O
health	B-O
should	B-O
be	B-O
considered	B-O
as	B-O
long	B-O
as	B-O
its	B-O
frequency	B-O
in	B-O
the	B-O
community	B-O
justifies	B-O
its	B-O
monitoring.	B-O
The	B-O
magnitude	B-O
of	I-LF
the	B-O
impact	B-O
may	B-O
be	B-O
considered	B-O
among	B-O
the	B-O
prioritization	B-O
criteria	B-O
in	B-O
order	B-O
to	I-LF
limit	B-O
the	B-O
list.	B-O
Multimorbid	B-O
potential	B-O
of	I-LF
conditions	B-O
and	B-O
meanings	B-O
of	I-LF
the	B-O
combinations	B-O
This	B-O
study	B-O
confirmed	B-O
that	B-O
several	B-O
conditions	B-O
have	B-O
a	B-O
high	B-O
“multimorbid	B-O
potential,”	B-O
i.e.,	B-O
a	B-O
high	B-O
possibility	B-O
of	I-LF
being	B-O
associated	B-O
with	B-O
other	B-O
conditions,	B-O
which	B-O
is	B-O
notably	B-O
the	B-O
case	B-O
with	B-O
vasculometabolic	B-O
and	B-O
musculoskeletal	B-O
conditions,	B-O
chronic	B-LF
obstructive	I-LF
pulmonary	I-LF
disease,	B-O
and	B-O
especially	B-O
mental	B-O
disorders.	B-O
These	B-O
conditions	B-O
were	B-O
found	B-O
in	B-O
many	B-O
dyads	B-O
and	B-O
triads	B-O
in	B-O
line	B-O
with	B-O
those	B-O
retrieved	B-O
by	B-O
Prados-Torres	B-O
and	B-O
colleagues	B-O
and	B-O
Violan	B-O
and	B-O
colleagues	B-O
.	B-O
This	B-O
suggests	B-O
that	B-O
interventions	B-O
aimed	B-O
at	B-O
reducing	B-O
the	B-O
incidence	B-O
of	I-LF
conditions	B-O
with	B-O
a	B-O
high	B-O
multimorbid	B-O
potential	B-O
could	B-O
be	B-O
an	B-O
effective	B-O
way	B-O
to	I-LF
alleviate	B-O
the	B-O
burden	B-O
of	I-LF
multimorbidity,	B-O
which	B-O
should	B-O
thus	B-O
be	B-O
prioritized.	B-O
On	B-O
the	B-O
contrary,	B-O
as	B-O
already	B-O
reported	B-O
,	B-O
most	B-O
cancers,	B-O
multiple	B-LF
sclerosis,	B-O
and	B-O
dementia	B-O
occur	B-O
in	B-O
a	B-O
more	B-O
isolated	B-O
manner,	B-O
although	B-O
the	B-O
underdiagnosis	B-O
or	B-O
underreporting	B-O
of	I-LF
comorbid	B-O
conditions	B-O
cannot	B-O
be	B-O
excluded,	B-O
in	B-O
particular	B-O
for	B-O
dementia.	B-O
One	B-O
of	I-LF
the	B-O
original	B-O
aspects	B-O
of	I-LF
this	B-O
study,	B-O
however,	B-O
was	B-O
the	B-O
analysis	B-O
of	I-LF
more	B-O
than	B-O
200	B-O
dyads	B-O
in	B-O
terms	B-O
of	I-LF
plausible	B-O
etiological	B-O
pathways.	B-O
Using	B-O
the	B-O
typology	B-O
of	I-LF
Valderas	B-O
and	B-O
colleagues	B-O
,	B-O
this	B-O
analysis	B-O
gave	B-O
meaning	B-O
to	I-LF
the	B-O
combinations	B-O
of	I-LF
conditions	B-O
and	B-O
provides	B-O
clues	B-O
for	B-O
their	B-O
clinical	B-O
management	B-O
beyond	B-O
the	B-O
simple	B-O
mechanism	B-O
of	I-LF
complication,	B-O
which	B-O
only	B-O
drives	B-O
a	B-O
part	B-O
of	I-LF
them.	B-O
In	B-O
particular,	B-O
associations	B-O
probably	B-O
driven	B-O
by	B-O
bidirectional	B-O
causality	B-O
are	B-O
especially	B-O
important	B-O
in	B-O
the	B-O
clinical	B-O
setting	B-O
if	B-O
one	B-O
condition	B-O
is	B-O
more	B-O
treatable	B-O
than	B-O
another	B-O
as	B-O
in	B-O
the	B-O
case	B-O
of	I-LF
depression	B-O
and	B-O
low	B-O
back	B-O
pain.	B-O
Associations	B-O
that	B-O
share	B-O
the	B-O
same	B-O
risk	I-LF
factors	B-O
also	B-O
require	B-O
attention,	B-O
as	B-O
these	B-O
factors	B-O
may	B-O
be	B-O
more	B-O
easily	B-O
detected	B-O
and	B-O
tackled	B-O
in	B-O
multimorbid	B-O
participants.	B-O
In	B-O
this	B-O
regard,	B-O
the	B-O
major	B-O
(and	B-O
often	B-O
causal)	B-O
role	B-O
played	B-O
by	B-O
obesity,	B-O
depression,	B-O
and	B-O
anxiety	B-O
in	B-O
many	B-O
associations,	B-O
either	B-O
as	B-O
a	B-O
component	B-O
or	B-O
as	B-O
a	B-O
shared	B-O
risk	I-LF
factor	B-O
of	I-LF
the	B-O
components,	B-O
should	B-O
be	B-O
stressed,	B-O
especially	B-O
as	B-O
these	B-O
conditions	B-O
are	B-O
not	B-O
considered	B-O
or	B-O
are	B-O
even	B-O
excluded	B-O
in	B-O
several	B-O
multimorbidity	B-O
studies	B-O
[	B-O
39	B-O
,	B-O
40	B-O
].	B-O
Impact	B-O
and	B-O
joint	B-O
effects	B-O
of	I-LF
multimorbid	B-O
associations	B-O
This	B-O
study	B-O
is	B-O
one	B-O
of	I-LF
the	B-O
first	B-O
to	I-LF
analytically	B-O
address	B-O
the	B-O
impact	B-O
and	B-O
joint	B-O
effects	B-O
of	I-LF
a	B-O
large	B-O
number	B-O
of	I-LF
multimorbid	B-O
associations	B-O
on	B-O
activity	B-O
limitations	B-O
and	B-O
perceived	B-O
heath.	B-O
These	B-O
different	B-O
but	B-O
related	B-O
aspects	B-O
largely	B-O
determine	B-O
the	B-O
potential	B-O
severity	B-O
of	I-LF
the	B-O
multimorbid	B-O
associations.	B-O
As	B-O
they	B-O
directly	B-O
reflect	B-O
the	B-O
burden	B-O
experienced	B-O
by	B-O
the	B-O
participants,	B-O
the	B-O
impact	B-O
of	I-LF
multimorbid	B-O
associations	B-O
on	B-O
health	B-O
indicators	B-O
is	B-O
best	B-O
investigated	B-O
and	B-O
reported	B-O
in	B-O
terms	B-O
of	I-LF
absolute	B-O
risks.	B-O
Diseases	I-LF
with	B-O
complications	B-O
have	B-O
the	B-O
greatest	B-O
impact	B-O
on	B-O
health,	B-O
but	B-O
associations	B-O
of	I-LF
conditions	B-O
that	B-O
affect	B-O
different	B-O
systems	B-O
also	B-O
appear	B-O
to	I-LF
have	B-O
large	B-O
impacts.	B-O
Associations	B-O
concerning	B-O
systems	B-O
involved	B-O
in	B-O
locomotion	B-O
(cardiovascular,	B-O
respiratory,	B-O
osteoarticular),	B-O
and	B-O
to	I-LF
a	B-O
lesser	B-O
extent,	B-O
those	B-O
affecting	B-O
sensorial	B-O
functions	B-O
strongly	B-O
impact	B-O
both	B-O
activity	B-O
limitations	B-O
and	B-O
perceived	B-O
health,	B-O
whereas	B-O
associations	B-O
with	B-O
mental	B-O
disorders	B-O
mostly	B-O
impact	B-O
perceived	B-O
health.	B-O
The	B-O
highly	B-O
different	B-O
impacts	B-O
resulting	B-O
from	B-O
the	B-O
association	B-O
of	I-LF
2,	B-O
3,	B-O
or	B-O
even	B-O
4	B-O
conditions,	B-O
which	B-O
form	B-O
the	B-O
bulk	B-O
of	I-LF
the	B-O
multimorbidity	B-O
burden,	B-O
make	B-O
the	B-O
simple	B-O
counting	B-O
of	I-LF
conditions	B-O
inadequate	B-O
in	B-O
order	B-O
to	I-LF
characterize	B-O
the	B-O
burden	B-O
of	I-LF
multimorbidity.	B-O
This	B-O
inadequacy	B-O
has	B-O
recently	B-O
been	B-O
pointed	B-O
out	B-O
with	B-O
regard	B-O
to	I-LF
the	B-O
impact	B-O
on	B-O
mortality	B-O
[	B-O
30	B-O
,	B-O
33	B-O
,	B-O
41	B-O
].	B-O
The	B-O
joint	B-O
effects	B-O
and	B-O
especially	B-O
the	B-O
interactions	B-O
of	I-LF
the	B-O
components	B-O
of	I-LF
associations,	B-O
which	B-O
are	B-O
more	B-O
closely	B-O
related	B-O
to	I-LF
biological	B-O
mechanisms	B-O
and	B-O
synergy	B-O
phenomena	B-O
,	B-O
probably	B-O
deserve	B-O
closer	B-O
attention.	B-O
In	B-O
this	B-O
study,	B-O
interactions	B-O
appeared	B-O
to	I-LF
be	B-O
extremely	B-O
variable	B-O
on	B-O
a	B-O
continuum	B-O
from	B-O
subadditive	B-O
to	I-LF
supermultiplicative.	B-O
The	B-O
associations	B-O
with	B-O
multiplicative	B-O
or	B-O
supermultiplicative	B-O
interactions,	B-O
which	B-O
included	B-O
obesity,	B-O
chronic	B-LF
obstructive	I-LF
pulmonary	I-LF
disease,	B-O
migraine,	B-O
and	B-O
certain	B-O
osteoarticular	B-O
pathologies	B-O
(inflammatory	B-O
arthritis	B-O
and	B-O
osteoarthritis),	B-O
were	B-O
the	B-O
most	B-O
deleterious	B-O
in	B-O
terms	B-O
of	I-LF
joint	B-O
effects.	B-O
By	B-O
contrast,	B-O
associations	B-O
involving	B-O
cardiometabolic	B-O
conditions,	B-O
low	B-O
back	B-O
pain,	B-O
osteoporosis,	B-O
injury	B-O
sequelae,	B-O
depression,	B-O
and	B-O
anxiety	B-O
were	B-O
less	B-O
unfavorable	B-O
for	B-O
this	B-O
effect.	B-O
These	B-O
results	B-O
have	B-O
important	B-O
implications	B-O
for	B-O
multimorbidity	B-O
measurements:	B-O
The	B-O
variable	B-O
impacts	B-O
and	B-O
joint	B-O
effects	B-O
of	I-LF
associations	B-O
would	B-O
seem	B-O
to	I-LF
preclude	B-O
the	B-O
exclusive	B-O
use	B-O
of	I-LF
a	B-O
raw	B-O
count	B-O
of	I-LF
conditions	B-O
to	I-LF
quantify	B-O
multimorbidity.	B-O
Strengths	B-O
and	B-O
limitations	B-O
of	I-LF
the	B-O
study	B-O
The	B-O
strengths	B-O
of	I-LF
this	B-O
study	B-O
include	B-O
the	B-O
use	B-O
of	I-LF
2	B-O
large	B-O
and	B-O
nationally	B-O
representative	B-O
surveys,	B-O
including	B-O
both	B-O
cross-sectional	B-O
and	B-O
longitudinal	B-O
data	B-O
on	B-O
60	B-O
chronic	B-LF
or	B-O
recurrent	B-O
conditions	B-O
and	B-O
6	B-O
health	B-O
status	B-O
measures,	B-O
and	B-O
the	B-O
use	B-O
of	I-LF
a	B-O
multistep,	B-O
systematic,	B-O
and	B-O
analytical	B-O
approach	B-O
to	I-LF
estimate	B-O
the	B-O
impact	B-O
and	B-O
the	B-O
joint	B-O
effects	B-O
of	I-LF
conditions	B-O
on	B-O
health	B-O
and	B-O
to	I-LF
assess	B-O
the	B-O
underlying	B-O
mechanisms	B-O
explaining	B-O
multimorbid	B-O
associations.	B-O
Moreover,	B-O
the	B-O
convergence	B-O
and	B-O
consistency	B-O
of	I-LF
results	B-O
across	B-O
surveys,	B-O
health	B-O
indicators,	B-O
and	B-O
time	B-O
frames	B-O
further	B-O
supports	B-O
the	B-O
robustness	B-O
of	I-LF
our	B-O
results,	B-O
which	B-O
was	B-O
of	I-LF
particular	B-O
importance	B-O
due	I-LF
the	B-O
type	B-O
I	B-O
statistical	B-O
error	B-O
that	B-O
inevitably	B-O
plagues	B-O
the	B-O
study	B-O
of	I-LF
numerous	B-O
morbidities.	B-O
This	B-O
study	B-O
also	B-O
has	B-O
some	B-O
limitations.	B-O
First,	B-O
despite	B-O
the	B-O
relatively	B-O
high	B-O
levels	B-O
of	I-LF
participation	B-O
and	B-O
follow-up	B-O
rates	B-O
achieved	B-O
in	B-O
the	B-O
2	B-O
nationwide	B-O
surveys	B-O
considered	B-O
here,	B-O
various	B-O
marginal	B-O
population	B-O
groups	B-O
(particularly	B-O
severely	B-O
ill	B-O
participants)	B-O
may	B-O
have	B-O
been	B-O
underrepresented,	B-O
thus	B-O
limiting	B-O
the	B-O
external	B-O
validity	B-O
of	I-LF
the	B-O
study.	B-O
Second,	B-O
self-reported	B-O
information	B-O
on	B-O
chronic	B-LF
or	B-O
recurrent	B-O
conditions	B-O
could	B-O
be	B-O
subject	B-O
to	I-LF
an	B-O
information	B-O
bias	B-O
due	I-LF
to	I-LF
social	B-O
desirability	B-O
(especially	B-O
mental	B-O
health	B-O
conditions),	B-O
age,	B-O
and	B-O
selective	B-O
recall	B-O
(symptom-based	B-O
conditions	B-O
are	B-O
reported	B-O
more	B-O
frequently	B-O
in	B-O
surveys	B-O
).	B-O
For	B-O
many	B-O
of	I-LF
the	B-O
studied	B-O
conditions,	B-O
frequencies	B-O
(1-year	B-O
or	B-O
lifetime	B-O
frame)	B-O
were	B-O
similar	B-O
to	I-LF
estimates	B-O
from	B-O
previous	B-O
studies	B-O
conducted	B-O
in	B-O
France	B-O
except	B-O
for	B-O
obesity	B-O
(when	B-O
compared	B-O
to	I-LF
studies	B-O
where	B-O
height	B-O
and	B-O
weight	B-O
were	B-O
measured	B-O
),	B-O
and	B-O
for	B-O
conditions	B-O
requiring	B-O
institutionalization	B-O
such	B-O
as	B-O
dementia	B-O
or	B-O
schizophrenia,	B-O
which	B-O
were	B-O
less	B-O
prevalent	B-O
than	B-O
expected.	B-O
Underestimation	B-O
of	I-LF
weight	B-O
may	B-O
represent	B-O
a	B-O
serious	B-O
problem	B-O
in	B-O
terms	B-O
of	I-LF
the	B-O
control	B-O
of	I-LF
confounding	B-O
factors,	B-O
since	B-O
obesity	B-O
is	B-O
involved	B-O
in	B-O
many	B-O
multimorbid	B-O
associations.	B-O
In	B-O
other	B-O
conditions,	B-O
we	B-O
presume	B-O
that	B-O
these	B-O
biases	B-O
mostly	B-O
had	B-O
a	B-O
nondifferential	B-O
effect	B-O
on	B-O
health	B-O
indicators,	B-O
possibly	B-O
with	B-O
the	B-O
exception	B-O
of	I-LF
the	B-O
impact	B-O
of	I-LF
disease	I-LF
severity	B-O
on	B-O
recall,	B-O
as	B-O
more	B-O
severe	B-O
conditions	B-O
were	B-O
more	B-O
likely	B-O
to	I-LF
be	B-O
recalled	B-O
and	B-O
associated	B-O
with	B-O
poorer	B-O
health	B-O
status	B-O
(severity	B-O
was	B-O
not	B-O
directly	B-O
assessed	B-O
in	B-O
this	B-O
study,	B-O
as	B-O
in	B-O
most	B-O
others	B-O
conducted	B-O
to	I-LF
date	B-O
on	B-O
multimorbidity	B-O
[	B-O
21	B-O
,	B-O
45	B-O
]).	B-O
However,	B-O
a	B-O
lack	B-O
of	I-LF
sensitivity	B-O
in	B-O
the	B-O
reported	B-O
information	B-O
is	B-O
preferable	B-O
to	I-LF
a	B-O
lack	B-O
of	I-LF
specificity	B-O
in	B-O
terms	B-O
of	I-LF
the	B-O
nondifferential	B-O
misclassification	B-O
bias	B-O
observed	B-O
in	B-O
association	B-O
studies	B-O
.	B-O
Third,	B-O
the	B-O
implementation	B-O
of	I-LF
the	B-O
approach	B-O
to	I-LF
investigating	B-O
the	B-O
etiological	B-O
pathways	B-O
underlying	B-O
multimorbid	B-O
associations,	B-O
using	B-O
the	B-O
typology	B-O
proposed	B-O
by	B-O
Valderas	B-O
and	B-O
colleagues	B-O
,	B-O
suffers	B-O
from	B-O
several	B-O
limitations:	B-O
The	B-O
empirical	B-O
analyses	B-O
used	B-O
to	I-LF
classify	B-O
into	B-O
“chance	B-O
only”	B-O
and	B-O
“confounding”	B-O
categories	B-O
may	B-O
have	B-O
been	B-O
vulnerable	B-O
to	I-LF
incomplete	B-O
data	B-O
(unrecorded	B-O
conditions),	B-O
to	I-LF
the	B-O
cross-sectional	B-O
nature	B-O
of	I-LF
part	B-O
of	I-LF
them,	B-O
and	B-O
sometimes	B-O
to	I-LF
the	B-O
lack	B-O
of	I-LF
power;	B-O
and	B-O
the	B-O
literature	B-O
searching	B-O
reflects	B-O
the	B-O
current	B-O
knowledge,	B-O
limited	B-O
as	B-O
regards	B-O
causal	B-O
associations	B-O
between	B-O
many	B-O
conditions.	B-O
Formal	B-O
mediation	B-O
analyses	B-O
would	B-O
have	B-O
been	B-O
preferable	B-O
but	B-O
were	B-O
far	B-O
from	B-O
being	B-O
achievable	B-O
in,	B-O
and	B-O
also	B-O
beyond	B-O
the	B-O
scope	B-O
of,	B-O
this	B-O
study.	B-O
Fourth,	B-O
this	B-O
study	B-O
refrained	B-O
from	B-O
using	B-O
data	B-O
reduction	B-O
methods	B-O
such	B-O
as	B-O
factor	B-O
or	B-O
cluster	B-O
analyses	B-O
to	I-LF
investigate	B-O
disease	I-LF
clustering	B-O
into	B-O
“patterns.”	B-O
The	B-O
implementation	B-O
of	I-LF
these	B-O
methods	B-O
raises	B-O
various	B-O
problems,	B-O
many	B-O
of	I-LF
which	B-O
still	B-O
need	B-O
to	I-LF
be	B-O
resolved	B-O
.	B-O
The	B-O
consideration	B-O
of	I-LF
disease	I-LF
combinations	B-O
in	B-O
dyads/triads/tetrads,	B-O
as	B-O
undertaken	B-O
in	B-O
this	B-O
study,	B-O
actually	B-O
addressed	B-O
patterns	B-O
in	B-O
three-quarters	B-O
of	I-LF
multimorbid	B-O
participants	B-O
and	B-O
also	B-O
shed	B-O
light	B-O
on	B-O
the	B-O
process	B-O
of	I-LF
morbidity	B-O
aggregation	B-O
(multimorbidity	B-O
first	B-O
involves	B-O
two	B-O
conditions,	B-O
then	B-O
three,	B-O
then	B-O
four,	B-O
and	B-O
so	B-O
on).	B-O
Fifth,	B-O
unmeasured	B-O
or	B-O
incompletely	B-O
controlled	B-O
biological	B-O
confounding	B-O
cannot	B-O
be	B-O
excluded.	B-O
Indeed,	B-O
control	B-O
for	B-O
confounding	B-O
is	B-O
necessary	B-O
when	B-O
considering	B-O
interactions	B-O
.	B-O
The	B-O
implications	B-O
of	I-LF
this	B-O
unquantifiable	B-O
confounding	B-O
would	B-O
be	B-O
primarily	B-O
an	B-O
attenuation	B-O
of	I-LF
the	B-O
associations.	B-O
Finally,	B-O
despite	B-O
the	B-O
large	B-O
sample	B-O
size,	B-O
the	B-O
power	B-O
was	B-O
limited	B-O
to	I-LF
detecting	B-O
small	B-O
effects	B-O
associated	B-O
with	B-O
less	B-O
frequent	B-O
conditions	B-O
or	B-O
even	B-O
moderate	B-O
effects	B-O
in	B-O
longitudinal	B-O
analyses.	B-O
The	B-O
study	B-O
of	I-LF
mortality	B-O
was	B-O
clearly	B-O
underpowered	B-O
due	I-LF
to	I-LF
the	B-O
low	B-O
number	B-O
of	I-LF
deaths	B-O
observed	B-O
in	B-O
the	B-O
ESPS	B-AC
survey.	B-O
Policy	B-O
and	B-O
research	B-O
implications	B-O
The	B-O
lack	B-O
of	I-LF
methodological	B-O
consensus	B-O
or	B-O
consistent	B-O
approaches	B-O
for	B-O
studying	B-O
multimorbidity	B-O
has	B-O
been	B-O
a	B-O
serious	B-O
impediment	B-O
for	B-O
the	B-O
development	B-O
of	I-LF
appropriate	B-O
control	B-O
and	B-O
prevention	B-O
strategies.	B-O
The	B-O
proposed	B-O
approach	B-O
reported	B-O
in	B-O
this	B-O
paper	B-O
can	B-O
guide	B-O
future	B-O
contributions	B-O
with	B-O
the	B-O
aim	B-O
to	I-LF
gain	B-O
a	B-O
better	B-O
understanding	B-O
and	B-O
awareness	B-O
of	I-LF
the	B-O
different	B-O
aspects	B-O
of	I-LF
multimorbidity.	B-O
Although	B-O
undertaken	B-O
in	B-O
a	B-O
single	B-O
country	B-O
(France),	B-O
this	B-O
study	B-O
is	B-O
replicable,	B-O
as	B-O
exemplified	B-O
by	B-O
the	B-O
use	B-O
of	I-LF
several	B-O
survey	B-O
datasets.	B-O
It	B-O
could	B-O
therefore	B-O
be	B-O
readily	B-O
implemented	B-O
in	B-O
many	B-O
countries	B-O
with	B-O
existing	B-O
systems	B-O
for	B-O
the	B-O
surveillance	B-O
of	I-LF
chronic	B-LF
diseases.	B-O
Multimorbidity	B-O
is	B-O
definitely	B-O
not	B-O
only	B-O
a	B-O
problem	B-O
of	I-LF
old	B-O
age;	B-O
identification	B-O
and	B-O
monitoring	B-O
should	B-O
be	B-O
implemented	B-O
as	B-O
early	B-O
as	B-O
midlife,	B-O
possibly	B-O
earlier	B-O
in	B-O
disadvantaged	B-O
groups.	B-O
Multimorbidity	B-O
assessments	B-O
should	B-O
rapidly	B-O
move	B-O
beyond	B-O
the	B-O
simple	B-O
counting	B-O
of	I-LF
chronic	B-LF
conditions	B-O
of	I-LF
any	B-O
kind	B-O
by	B-O
including	B-O
dozens	B-O
of	I-LF
chronic	B-LF
conditions	B-O
that	B-O
impact	B-O
health	B-O
and	B-O
taking	B-O
into	B-O
account	B-O
variable	B-O
impacts	B-O
and	B-O
joint	B-O
effects	B-O
of	I-LF
component	B-O
conditions	B-O
(e.g.,	B-O
monitoring	B-O
the	B-O
most	B-O
frequent	B-O
and	B-O
impacting	B-O
dyads	B-O
or	B-O
triads).	B-O
Approaches	B-O
to	I-LF
reduce	B-O
the	B-O
incidence	B-O
of	I-LF
these	B-O
combinations	B-O
and	B-O
minimize	B-O
their	B-O
impact	B-O
should	B-O
also	B-O
be	B-O
a	B-O
priority	B-O
for	B-O
improving	B-O
the	B-O
health	B-O
of	I-LF
multimorbid	B-O
participants	B-O
and	B-O
reducing	B-O
their	B-O
impact	B-O
on	B-O
healthcare	B-O
resources.	B-O
Further	B-O
research	B-O
is	B-O
needed	B-O
to	I-LF
evaluate	B-O
the	B-O
influence	B-O
of	I-LF
the	B-O
data	B-O
collection	B-O
method	B-O
(self-reports,	B-O
medical	B-O
records,	B-O
administrative	B-O
data)	B-O
and	B-O
the	B-O
comprehensiveness	B-O
of	I-LF
data	B-O
sources	B-O
on	B-O
medical	B-O
conditions,	B-O
which	B-O
should	B-O
definitely	B-O
include	B-O
obesity	B-O
and	B-O
mental	B-O
disorders.	B-O
Longitudinal	B-O
studies	B-O
of	I-LF
trajectories	B-O
of	I-LF
multimorbid	B-O
aggregations	B-O
according	B-O
to	I-LF
age,	B-O
sex,	B-O
and	B-O
socioeconomic	B-O
status	B-O
and	B-O
their	B-O
impacts	B-O
are	B-O
also	B-O
required,	B-O
along	B-O
with	B-O
fundamental	B-O
and	B-O
clinical	B-O
research	B-O
on	B-O
pathological	B-O
interactions,	B-O
notably	B-O
between	B-O
somatic	B-O
and	B-O
mental	B-O
disorders.	B-O
The	B-O
clinical	B-O
implications	B-O
of	I-LF
the	B-O
(statistical)	B-O
concept	B-O
of	I-LF
the	B-O
interaction	I-LF
continuum	B-O
from	B-O
subadditive	B-O
to	I-LF
supermultiplicative	B-O
should	B-O
be	B-O
scrutinized.	B-O
Without	B-O
much	B-O
delay,	B-O
however,	B-O
multimorbid	B-O
combinations	B-O
with	B-O
large	B-O
health	B-O
impacts	B-O
and	B-O
most	B-O
deleterious	B-O
interactions	B-O
should	B-O
be	B-O
appropriately	B-O
monitored	B-O
and	B-O
managed	B-O
within	B-O
the	B-O
healthcare	B-O
system.	B-O
Supporting	B-O
information	B-O
S1	B-O
STROBE	B-AC
Checklist.	B-O
Checklist	B-O
for	B-O
Strengthening	B-O
the	B-O
Reporting	B-O
of	I-LF
Observational	B-O
Studies	B-O
in	B-O
Epidemiology	B-O
(STROBE).	B-O
(DOCX)	B-O
S1	B-O
Table.	B-O
Description	B-O
of	I-LF
the	B-O
studied	B-O
samples	B-O
(ESPS	B-O
and	B-O
HSM	B-AC
surveys).	B-O
(DOCX)	B-O
S2	B-O
Table.	B-O
Associations	B-O
of	I-LF
conditions	B-O
with	B-O
activity	B-O
limitations,	B-O
perceived	B-O
health,	B-O
or	B-O
mortality	B-O
in	B-O
the	B-O
ESPS	B-AC
and	B-O
HSM	B-AC
surveys.	B-O
(DOCX)	B-O
S3	B-O
Table.	B-O
Impact	B-O
of	I-LF
studied	B-O
chronic	B-LF
conditions	B-O
on	B-O
activity	B-O
limitations	B-O
and	B-O
perceived	B-O
health	B-O
in	B-O
the	B-O
ESPS	B-AC
and	B-O
HSM	B-AC
surveys.	B-O
(DOCX)	B-O
S4	B-O
Table.	B-O
Risk	B-O
of	I-LF
multimorbidity,	B-O
defined	B-O
as	B-O
having	B-O
at	B-O
least	B-O
2	B-O
of	I-LF
the	B-O
48	B-O
selected	B-O
conditions,	B-O
associated	B-O
with	B-O
age,	B-O
sex,	B-O
and	B-O
socioeconomic	B-O
status	B-O
indicators	B-O
(education	B-O
level,	B-O
occupation,	B-O
and	B-O
household	B-O
income)	B-O
as	B-O
estimated	B-O
in	B-O
multiple	B-LF
logistic	B-O
regression	B-O
models.	B-O
(DOCX)	B-O
S5	B-O
Table.	B-O
Number	B-O
of	I-LF
selected	B-O
conditions	B-O
and	B-O
prevalence	B-O
of	I-LF
multimorbidity	B-O
according	B-O
to	I-LF
age	B-O
and	B-O
sex.	B-O
(DOCX)	B-O
S6	B-O
Table.	B-O
Risk	B-O
of	I-LF
multimorbidity	B-O
(vs	B-O
monomorbidity)	B-O
and	B-O
number	B-O
of	I-LF
conditions	B-O
associated	B-O
with	B-O
each	B-O
of	I-LF
the	B-O
48	B-O
chronic	B-LF
conditions	B-O
retained.	B-O
(DOCX)	B-O
S7	B-O
Table.	B-O
Weighted	B-O
frequency	B-O
of	I-LF
dyads	B-O
of	I-LF
conditions,	B-O
strength	B-O
of	I-LF
associations,	B-O
and	B-O
plausible	B-O
etiological	B-O
pathways	B-O
explaining	B-O
the	B-O
associations.	B-O
(DOCX)	B-O
S8	B-O
Table.	B-O
Weighted	B-O
frequency	B-O
of	I-LF
triads	B-O
and	B-O
tetrads	B-O
of	I-LF
conditions.	B-O
(DOCX)	B-O
S9	B-O
Table.	B-O
Impact	B-O
of	I-LF
associated	B-O
conditions	B-O
(dyads)	B-O
on	B-O
activity	B-O
limitations	B-O
and	B-O
perceived	B-O
health	B-O
in	B-O
the	B-O
ESPS	B-AC
and	B-O
HSM	B-AC
surveys.	B-O
(DOCX)	B-O
S10	B-O
Table.	B-O
Impact	B-O
of	I-LF
associated	B-O
conditions	B-O
(triads	B-O
and	B-O
tetrads)	B-O
on	B-O
activity	B-O
limitations	B-O
and	B-O
perceived	B-O
health	B-O
in	B-O
the	B-O
ESPS	B-AC
and	B-O
HSM	B-AC
surveys.	B-O
(DOCX)	B-O
S11	B-O
Table.	B-O
Joint	B-O
effects	B-O
of	I-LF
dyads	B-O
of	I-LF
associated	B-O
conditions	B-O
on	B-O
activity	B-O
limitations	B-O
(severely	B-O
limited	B-O
in	B-O
GALI,	B-O
limited	B-O
in	B-O
≥3	B-O
ADLs	B-O
or	B-O
≥2	B-O
IADLs,	B-O
new	B-O
limitation)	B-O
and	B-O
perceived	B-O
health	B-O
(bad	B-O
or	B-O
very	B-O
bad	B-O
SRH,	B-O
new	B-O
health	B-O
deterioration)	B-O
in	B-O
the	B-O
ESPS	B-AC
and	B-O
HSM	B-AC
surveys	B-O
when	B-O
the	B-O
conditions	B-O
were	B-O
retained	B-O
in	B-O
the	B-O
final	B-O
models	B-O
presented	B-O
in	B-O
Table	B-O
1	B-O
.	B-O
(DOCX)	B-O
S12	B-O
Table.	B-O
Joint	B-O
effects	B-O
of	I-LF
two-by-two	B-O
associated	B-O
conditions	B-O
within	B-O
triads	B-O
on	B-O
activity	B-O
limitations	B-O
and	B-O
perceived	B-O
health	B-O
in	B-O
the	B-O
ESPS	B-AC
and	B-O
HSM	B-AC
surveys	B-O
when	B-O
the	B-O
conditions	B-O
were	B-O
retained	B-O
in	B-O
the	B-O
final	B-O
models	B-O
presented	B-O
in	B-O
Table	B-O
1	B-O
.	B-O
(DOCX)	B-O
Acknowledgments	B-O
Disclaimer	B-O
The	B-O
present	B-O
paper	B-O
represents	B-O
the	B-O
opinions	B-O
of	I-LF
the	B-O
authors	B-O
and	B-O
does	B-O
not	B-O
necessarily	B-O
reflect	B-O
the	B-O
position	B-O
of	I-LF
their	B-O
employers.	B-O
